SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla gets final approval for Albendazole Tablets

24 Sep 2018 Evaluate

Cipla has received final approval for its Abbreviated New Drug Application (ANDA) Albendazole Tablets 200mg from the United States Food and Drug Administration (USFDA). The company’s Albendazole Tablets 200mg is AB-rated generic therapeutic equivalent version of Impax Laboratories, Inc.'s, Albenza.

It is an anthelmintic drug indicated for use in treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium and cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus. According to IQVIA (IMS Health), Albenza had US sales of around $99 million for the 12-month period ending July 2018. The product is available for shipping immediately.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Cipla Share Price

1328.25 -6.60 (-0.49%)
05-May-2026 12:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1820.15
Dr. Reddys Lab 1278.40
Cipla 1328.25
Zydus Lifesciences 908.00
Lupin 2337.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×